Symrise AG (SY1) - Net Assets
Based on the latest financial reports, Symrise AG (SY1) has net assets worth €3.74 Billion EUR (≈ $4.37 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€7.90 Billion ≈ $9.24 Billion USD) and total liabilities (€4.16 Billion ≈ $4.87 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore SY1 asset base for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €3.74 Billion |
| % of Total Assets | 47.35% |
| Annual Growth Rate | 12.09% |
| 5-Year Change | 15.06% |
| 10-Year Change | 116.03% |
| Growth Volatility | 16.3 |
Symrise AG - Net Assets Trend (2013–2025)
This chart illustrates how Symrise AG's net assets have evolved over time, based on quarterly financial data. Check tangible equity quality of Symrise AG to evaluate the tangible quality of the company's equity base.
Annual Net Assets for Symrise AG (2013–2025)
The table below shows the annual net assets of Symrise AG from 2013 to 2025. For live valuation and market cap data, see SY1 stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €3.74 Billion ≈ $4.37 Billion |
-6.91% |
| 2024-12-31 | €4.02 Billion ≈ $4.70 Billion |
+9.05% |
| 2023-12-31 | €3.69 Billion ≈ $4.31 Billion |
+2.10% |
| 2022-12-31 | €3.61 Billion ≈ $4.22 Billion |
+11.01% |
| 2021-12-31 | €3.25 Billion ≈ $3.80 Billion |
+37.71% |
| 2020-12-31 | €2.36 Billion ≈ $2.76 Billion |
-4.17% |
| 2019-12-31 | €2.46 Billion ≈ $2.88 Billion |
+26.74% |
| 2018-12-31 | €1.94 Billion ≈ $2.27 Billion |
+9.89% |
| 2017-12-31 | €1.77 Billion ≈ $2.07 Billion |
+2.15% |
| 2016-12-31 | €1.73 Billion ≈ $2.03 Billion |
+9.06% |
| 2015-12-31 | €1.59 Billion ≈ $1.86 Billion |
+10.90% |
| 2014-12-31 | €1.43 Billion ≈ $1.67 Billion |
+50.59% |
| 2013-12-31 | €951.06 Million ≈ $1.11 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Symrise AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 18741.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €1.93 Billion | 51.76% |
| Other Components | €1.79 Billion | 48.24% |
| Total Equity | €3.72 Billion | 100.00% |
Symrise AG Competitors by Market Cap
The table below lists competitors of Symrise AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Accor S. A.
PA:AC
|
$10.31 Billion |
|
China Spacesat Co Ltd
SHG:600118
|
$10.31 Billion |
|
CACI International Inc
NYSE:CACI
|
$10.33 Billion |
|
Cytokinetics Inc
NASDAQ:CYTK
|
$10.33 Billion |
|
Globalstar, Inc. Common Stock
NASDAQ:GSAT
|
$10.30 Billion |
|
CITIC Pacific Special Steel Group Co Ltd
SHE:000708
|
$10.29 Billion |
|
Futu Holdings Limited
F:6FHA
|
$10.28 Billion |
|
Samsung SDS Co Ltd
KO:018260
|
$10.27 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Symrise AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 3,981,180,000 to 3,719,628,000, a change of -261,552,000 (-6.6%).
- Net income of 249,333,000 contributed positively to equity growth.
- Dividend payments of 167,726,000 reduced retained earnings.
- Other factors decreased equity by 343,159,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €249.33 Million | +6.7% |
| Dividends Paid | €167.73 Million | -4.51% |
| Other Changes | €-343.16 Million | -9.23% |
| Total Change | €- | -6.57% |
Book Value vs Market Value Analysis
This analysis compares Symrise AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.24x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 6.53x to 3.24x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €13.19 | €86.12 | x |
| 2018-12-31 | €14.57 | €86.12 | x |
| 2019-12-31 | €17.77 | €86.12 | x |
| 2020-12-31 | €17.00 | €86.12 | x |
| 2021-12-31 | €22.81 | €86.12 | x |
| 2022-12-31 | €25.41 | €86.12 | x |
| 2023-12-31 | €25.98 | €86.12 | x |
| 2024-12-31 | €28.48 | €86.12 | x |
| 2025-12-31 | €26.61 | €86.12 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Symrise AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.70%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.06%
- • Asset Turnover: 0.62x
- • Equity Multiplier: 2.12x
- Recent ROE (6.70%) is below the historical average (12.76%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 18.12% | 9.42% | 0.83x | 2.32x | €77.23 Million |
| 2014 | 13.08% | 8.73% | 0.53x | 2.83x | €43.58 Million |
| 2015 | 15.74% | 9.49% | 0.62x | 2.67x | €89.94 Million |
| 2016 | 15.11% | 8.70% | 0.61x | 2.84x | €85.51 Million |
| 2017 | 15.78% | 9.02% | 0.64x | 2.73x | €99.00 Million |
| 2018 | 14.55% | 8.73% | 0.64x | 2.60x | €86.13 Million |
| 2019 | 12.39% | 8.75% | 0.57x | 2.47x | €57.59 Million |
| 2020 | 13.33% | 8.72% | 0.59x | 2.58x | €76.69 Million |
| 2021 | 11.76% | 9.80% | 0.58x | 2.08x | €56.13 Million |
| 2022 | 7.88% | 6.06% | 0.59x | 2.19x | €-75.13 Million |
| 2023 | 9.38% | 7.20% | 0.60x | 2.16x | €-22.65 Million |
| 2024 | 12.01% | 9.57% | 0.60x | 2.09x | €80.11 Million |
| 2025 | 6.70% | 5.06% | 0.62x | 2.12x | €-122.63 Million |
Industry Comparison
This section compares Symrise AG's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $840,318,546
- Average return on equity (ROE) among peers: -45.68%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Symrise AG (SY1) | €3.74 Billion | 18.12% | 1.11x | $10.30 Billion |
| LIFELINE SPAC I OYJ A EO1 (0CD) | $3.93 Million | 0.00% | 25.02x | $261.36 Million |
| GRAPHENE MANUFACT.GROUP (0GF) | $8.69 Million | -107.23% | 0.84x | $185.36 Million |
| Orion Engineered Carbons SA (0OE) | $319.70 Million | 42.13% | 4.10x | $327.05 Million |
| COVESTRO AG SP.ADR 1/2 (1CO1) | $7.12 Billion | -3.82% | 1.05x | $11.11 Billion |
| H&R GmbH & Co. KGaA (2HRA) | $342.74 Million | 9.37% | 0.93x | $183.88 Million |
| LOOP INDUSTRIES DL-001 (3L9) | $33.74 Million | -63.14% | 0.20x | $35.88 Million |
| Dotz Nano Ltd (57N) | $2.40 Million | -273.77% | 1.77x | $4.51 Million |
| TIDEWATER RENEWABLES LTD (7GZ) | $515.60 Million | 0.00% | 0.42x | $233.52 Million |
| DIRECTA PLUS PLC LS-0025 (88K) | $16.03 Million | -22.78% | 0.36x | $2.35 Million |
| TEKNA HOLDING ASA NK 2 (8VB) | $38.35 Million | -37.60% | 0.99x | $67.10 Million |
About Symrise AG
Symrise AG operates as a supplier of fragrances, flavorings, cosmetic base materials and active ingredients, and functional ingredients and solutions in Europe, Africa, the Middle East, North America, the Asia Pacific, and Latin America. It operates in two segments, Taste, Nutrition & Health; and Scent & Care. The Taste, Nutrition & Health segment provides functional ingredients and product solut… Read more